What Factors Can Skew a PSA Test Result?

Dozens of conditions, activities, and medications can push your PSA number up or pull it down independently of prostate cancer. A large real-world cohort study found that nearly half of elevated PSA results turned out to be false positives, with urinary tract infections, advancing age, and prostate enlargement among the strongest drivers of misleading readings.¹ Understanding what can throw the number off helps you have a more useful conversation with your doctor and avoid unnecessary anxiety or, worse, unnecessary biopsies.

Prostate Size and Normal Aging

PSA is produced by prostate tissue, so the more tissue there is, the more PSA leaks into your blood. Men with benign prostatic hyperplasia, the gradual enlargement that affects most men as they get older, tend to have higher PSA levels even when nothing cancerous is going on. Research consistently shows a positive correlation between prostate volume and both total and free PSA, with the relationship growing stronger as the gland gets bigger.² The inner gland, which is the part that tends to grow in BPH, correlates particularly well with PSA levels.³

Age compounds the issue. As men get older, their prostates typically enlarge, and PSA drifts upward with it. That same false-positive cohort study found that men aged 61 to 70 were roughly three times more likely to get a false-positive PSA result than men under 45, and men over 70 were about four and a half times more likely.¹ This is one reason some guidelines use age-adjusted PSA thresholds rather than a single cutoff for everyone.

Infections and Inflammation

Infections in or near the prostate are some of the most dramatic PSA disruptors. The mechanism is straightforward: inflammation damages the barriers that normally keep PSA confined inside prostate glands, letting large amounts spill into the bloodstream.⁴ In acute bacterial prostatitis, this leakage can be extreme. One case report documented a PSA of 1,398 ng/mL, hundreds of times above normal, in a patient with acute prostatitis on a background of BPH.⁵ That is an outlier, but even garden-variety urinary tract infections substantially raise the odds of a falsely elevated reading. In the cohort study mentioned earlier, patients with a UTI were over eight times more likely to have a false-positive PSA than those without one.¹

Chronic prostatitis and asymptomatic prostatic inflammation are trickier. They do not cause the same towering spikes as acute infection, but they can nudge PSA into an ambiguous zone. One study of men with PSA levels in the 2.5 to 10 ng/mL gray area found that those with multifocal inflammation had higher PSA readings than those with only focal inflammation, though the overall prevalence of inflammation did not clearly predict whether PSA was elevated.⁶ The practical takeaway is that current European urology guidelines recommend deferring PSA testing until any infection has fully cleared and may wait up to a year after a febrile UTI for the number to normalize.⁴

Ejaculation and Sexual Activity

Ejaculation causes a short-lived bump in PSA. In a study comparing screening-age men and younger men, PSA rose significantly within an hour of ejaculation in both groups. By 24 hours later, though, the levels had returned to baseline in both groups, with no significant difference from the pre-ejaculation reading.⁷ In younger men, the spike was not large enough to cross the typical 4 ng/mL threshold, so it was clinically irrelevant. But for older men already hovering near a cutoff, the timing could matter. Most clinicians advise avoiding ejaculation for at least 24 to 48 hours before a scheduled PSA draw.

Long-Distance Cycling

Prolonged pressure on the perineum from a bicycle saddle mechanically agitates the prostate, and this shows up in blood work. A study of men aged 50 and over found that total PSA rose by an average of about 10% after a long-distance ride. That bump was enough to push roughly 5 to 6 percent of riders above normal thresholds who had been below them before.⁸ Both age and distance cycled correlated with the size of the increase. A separate pilot study confirmed the effect, showing significantly higher total and free PSA after a ride.⁹ Casual cycling around the neighborhood likely does not matter much, but if you are training for an event or commuting long distances by bike, schedule your blood draw for a day when you have not been in the saddle.

Acute Urinary Retention and Catheterization

If you have ever been unable to empty your bladder and needed a catheter, your PSA was almost certainly elevated at that point. Acute urinary retention roughly doubles PSA, and the effect can linger for about two weeks.¹⁰ In one series of patients presenting with acute retention, two-thirds had elevated PSA, with a mean value near 39 ng/mL.¹¹

A common worry is that the catheter itself causes the rise. Research suggests otherwise. A study measuring PSA before and after catheter insertion in retention patients found that the elevated reading was already present at baseline and did not change significantly after atraumatic catheterization.¹² The takeaway: it is the retention, not the catheter, that is distorting the number. But either way, a PSA drawn during or shortly after an episode of urinary retention should be interpreted cautiously.

Medications That Lower PSA

Some drugs suppress PSA production as a side effect, which can hide a genuine rise. The most important culprits are the 5-alpha reductase inhibitors, finasteride and dutasteride, widely prescribed for BPH and male-pattern hair loss. Finasteride typically cuts PSA by about half after 12 months of use. Dutasteride is even more potent, reducing PSA by roughly 60% at two years and about 66% at four years.¹³ The standard clinical workaround is to double whatever PSA reading you get in a man taking either drug. If your “corrected” PSA (the measured value times two) is above the threshold, further investigation is warranted.

Aspirin also appears to slightly lower baseline PSA. After adjusting for variables like age, body mass, and race, aspirin users showed statistically significant lower PSA values compared with nonusers, though the effect size is smaller than what 5-alpha reductase inhibitors produce. Other NSAIDs and statins did not show a meaningful impact in the same analysis.¹⁴

One supplement that often gets blamed without cause is saw palmetto, an herbal remedy popular for urinary symptoms. A well-designed randomized trial testing increasing doses of saw palmetto extract over 72 weeks found no meaningful difference in PSA between the treatment and placebo groups at any point during the study.¹⁵ Despite persistent rumors, saw palmetto does not appear to mask PSA.

Body Weight and Blood Volume

Obesity is an underappreciated PSA confounder. Heavier men tend to have lower PSA levels than leaner men, even when their prostates are the same size. The primary explanation is hemodilution: people with more body mass have a larger plasma volume, so the same amount of PSA is diluted into more blood, producing a lower reading.¹⁶ Researchers have tried correcting for this by multiplying PSA by estimated plasma volume to create a “PSA mass density” measure that correlates better with actual tumor volume in surgical specimens.¹⁷ These corrections are not yet standard in everyday practice, though, meaning heavier men may get falsely reassuring results. This is particularly worrying because some data suggest obese men are already at higher risk of aggressive prostate cancer being diagnosed late.

Testosterone and Hormonal Status

Because testosterone drives prostate cell activity, the hormone’s level affects how much PSA the gland produces. Men with low testosterone (hypogonadism) tend to have lower PSA readings, and research has shown that PSA can actually serve as a rough marker for testosterone status, correlating not just with total testosterone but with its biologically active fractions as well.¹⁸ Conversely, men who start testosterone replacement therapy often see their PSA climb, which can trigger a scare if nobody anticipated the shift. Your doctor should establish a new PSA baseline a few months into testosterone therapy and track changes from there.

The same hormonal logic applies in the context of gender-affirming care. Transgender women receiving estrogen therapy have dramatically suppressed testosterone, and their PSA values reflect it. In one cohort, the median PSA was just 0.02 ng/mL, and over a third of readings were completely undetectable. Even the highest value in the entire group was only 2.21 ng/mL, well below the standard screening threshold.¹⁹ This means that standard cutoffs do not apply to this population, and any detectable PSA in a transgender woman on long-term estrogen deserves careful attention.

Natural Fluctuation and Time of Day

Even in the absence of any interfering factor, your PSA is not a fixed number. It fluctuates from day to day and even over the course of a single day. Research in men with prostate cancer on active surveillance found considerable variability in serial PSA measurements, with individual values bouncing around enough that the probability of a reversal in PSA direction increased over time.²⁰ The authors concluded that no single PSA reading should drive a major decision like biopsy or treatment.

There is also a diurnal pattern. PSA tends to be higher in the morning and lower in the afternoon. In one study, the vast majority of patients (around 87%) showed a drop in PSA when measured later in the day. Among men whose morning PSA was above the commonly used 4 ng/mL cutoff, half dropped below that threshold by the afternoon.²¹ This is not trivial. Whether your blood is drawn at 8 a.m. or 3 p.m. could mean the difference between a normal result and one that triggers further workup. Most labs draw blood in the morning, which, somewhat unhelpfully, is when PSA is at its peak.

Genetic Variation in PSA Production

Some men are simply wired to produce more PSA than others, regardless of whether their prostate is healthy or not. Genome-wide association studies have identified genetic variants, particularly near the KLK3 gene (which encodes PSA itself), that explain a meaningful portion of the variation in PSA levels between individuals. Importantly, these variants increase PSA without increasing prostate cancer risk, meaning they contribute directly to false positives.²² Research into genetically adjusted PSA thresholds is ongoing but has not yet reached routine clinical use. For now, the practical lesson is that your baseline PSA is partly inherited, which is another reason a single elevated number without context can be misleading.

Biotin Supplements and Lab Assay Interference

This one catches almost everyone off guard. Many lab platforms use the biotin-streptavidin system to detect analytes, and high doses of supplemental biotin (vitamin B7, often found in hair-skin-nails supplements at doses far exceeding daily requirements) can directly interfere with these assays. Depending on the assay design, biotin interference can produce either falsely low or falsely high results.²³ For PSA specifically, most commonly used sandwich immunoassays tend to produce falsely low results in the presence of excess biotin. If you are taking a biotin supplement, especially at doses above 5 mg per day, mention it to your doctor and consider stopping it at least 72 hours before your blood draw. This applies to many other lab tests too, not just PSA.

How Multiple Factors Stack Up in Practice

In clinical reality, these confounders rarely show up in isolation. A 68-year-old man with an enlarged prostate, a mild chronic prostatitis he doesn’t know about, and a BMI of 32 has at least three factors pulling his PSA in different directions simultaneously. The enlargement and inflammation push it up; the hemodilution from his weight pushes it down. Whether his final reading is above or below the threshold depends on which forces win, and neither his doctor nor any algorithm can neatly partition how much each factor contributed.

This layering of confounders is a major reason why repeating an abnormal PSA before moving to imaging or biopsy is standard guidance. Your result can shift simply because of a different time of day, recent sexual activity, or a subclinical infection that resolved between draws. The false-positive rate in the real-world cohort study approached 47%, which means that for every two men flagged by an elevated PSA, roughly one does not have cancer.¹ A repeat draw under standardized conditions, meaning no recent ejaculation, no manipulation, no active infection, and ideally at a consistent time of day, dramatically improves the value of the number.

One interesting finding from that same cohort was that men with diabetes mellitus were actually less likely to have a false-positive PSA result. The reasons are not entirely clear, but lower circulating testosterone and altered prostate biology in diabetic men may dampen PSA production. It is a reminder that the PSA number exists inside a web of metabolic, hormonal, and genetic context, and the more of that context your doctor has, the better the number can be interpreted.